Department of Neuropsychiatry, Hirosaki-Aiseikai Hospital, Aomori, Japan.
Neuropsychopharmacol Rep. 2022 Sep;42(3):374-376. doi: 10.1002/npr2.12256. Epub 2022 May 4.
In this case report, an adolescent boy with sophophobia (fear of learning) is reported. Although psychoeducation about the condition was helpful to the patient, there was only a limited effect on his symptoms. Psychotropic treatment with escitalopram was initiated. He showed gradual improvement with this treatment, and there was only a limited effect on his symptoms. Hence, the patient was referred for psychotherapy, although he was unable to attend sessions. Augmentation with perospirone resulted in significant improvement. Research about pharmacological approaches to treat childhood and adolescent phobias is limited and requires further investigation.
本病例报告报道了一例患有 sophophobia（学习恐惧）的青少年男孩。尽管对该患者进行了有关该疾病的心理教育，但对其症状仅起到有限的作用。开始使用艾司西酞普兰进行精神药物治疗。随着这种治疗，他的病情逐渐改善，对其症状的影响有限。因此，尽管患者无法参加治疗，但还是将其转介进行心理治疗。加入哌罗匹隆后病情显著改善。关于治疗儿童和青少年恐惧症的药物治疗方法的研究有限，需要进一步研究。
